A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder
Clinical trial NCT06021522 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06021522
- Sponsor
- Emalex Biosciences Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-16
- Primary completion
- 2028-02-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.